{
  "current_page": 528286,
  "docs": [
    {
      "code": "COV_FCFPS_ARY",
      "column_names": [
        "Date",
        "Value"
      ],
      "description": "<p><b>Indicator Description<\/b> [Free Cash Flow per Share]: Free Cash Flow per Share is a valuation metric calculated by dividing <a href='COV_FCF_ARY'>[FCF]<\/a> by <a href='COV_SHARESWA_ARY'>[SHARESWA]<\/a>.<\/p> <p><b>Company Self Description<\/b> [Covidien plc]: We are a global leader in the development, manufacture and sale of healthcare products for use in clinical and home settings. Our products are found in almost every hospital in the United States, and we have a significant and growing presense in non-U.S. markets. Our mission is to create and deliver innovative healthcare solutions, developed in ethical collaboration with medical professionals, which enhance the quality of life for patients and improve the outcomes for our customers and shareholders.<\/p> <p><b>Dimension<\/b>: (As Reported - Annual) - ARY<\/p> <p><b>Statement<\/b>: Metrics<\/p> <p><b>Units<\/b>: currency/share<\/p> <p><b>Sector<\/b>: Healthcare<\/p> <p><b>Ticker<\/b>: COV<\/p> <p><b>Exchange<\/b>: NYSE<\/p> <p><b>Index Membership<\/b>: S&P500<\/p> ",
      "display_url": "http://www.sharadar.com/s/GrxxDFofSlKAGpNag",
      "frequency": "annual",
      "from_date": "2007-12-13",
      "id": 14041319,
      "name": "Covidien plc (NYSE:COV) - Free Cash Flow per Share (As Reported - Annual)",
      "premium": true,
      "private": false,
      "source_code": "SF1",
      "source_name": "Core US Fundamentals Data",
      "to_date": "2014-11-24",
      "type": null,
      "updated_at": "2014-11-25T05:27:33.694Z",
      "urlize_name": "Covidien-plc-NYSE-COV-Free-Cash-Flow-per-Share-As-Reported-Annual"
    },
    {
      "code": "COV_FCFPS_MRY",
      "column_names": [
        "Date",
        "Value"
      ],
      "description": "<p><b>Indicator Description<\/b> [Free Cash Flow per Share]: Free Cash Flow per Share is a valuation metric calculated by dividing <a href='COV_FCF_MRY'>[FCF]<\/a> by <a href='COV_SHARESWA_MRY'>[SHARESWA]<\/a>.<\/p> <p><b>Company Self Description<\/b> [Covidien plc]: We are a global leader in the development, manufacture and sale of healthcare products for use in clinical and home settings. Our products are found in almost every hospital in the United States, and we have a significant and growing presense in non-U.S. markets. Our mission is to create and deliver innovative healthcare solutions, developed in ethical collaboration with medical professionals, which enhance the quality of life for patients and improve the outcomes for our customers and shareholders.<\/p> <p><b>Dimension<\/b>: (Most Recent - Annual) - MRY<\/p> <p><b>Statement<\/b>: Metrics<\/p> <p><b>Units<\/b>: currency/share<\/p> <p><b>Sector<\/b>: Healthcare<\/p> <p><b>Ticker<\/b>: COV<\/p> <p><b>Exchange<\/b>: NYSE<\/p> <p><b>Index Membership<\/b>: S&P500<\/p> ",
      "display_url": "http://www.sharadar.com/s/GrxxDFofSlKAGpNag",
      "frequency": "annual",
      "from_date": "2005-09-30",
      "id": 14041321,
      "name": "Covidien plc (NYSE:COV) - Free Cash Flow per Share (Most Recent - Annual)",
      "premium": true,
      "private": false,
      "source_code": "SF1",
      "source_name": "Core US Fundamentals Data",
      "to_date": "2014-09-26",
      "type": null,
      "updated_at": "2014-11-25T05:27:33.640Z",
      "urlize_name": "Covidien-plc-NYSE-COV-Free-Cash-Flow-per-Share-Most-Recent-Annual"
    },
    {
      "code": "COV_FCFPS_MRQ",
      "column_names": [
        "Date",
        "Value"
      ],
      "description": "<p><b>Indicator Description<\/b> [Free Cash Flow per Share]: Free Cash Flow per Share is a valuation metric calculated by dividing <a href='COV_FCF_MRQ'>[FCF]<\/a> by <a href='COV_SHARESWA_MRQ'>[SHARESWA]<\/a>.<\/p> <p><b>Company Self Description<\/b> [Covidien plc]: We are a global leader in the development, manufacture and sale of healthcare products for use in clinical and home settings. Our products are found in almost every hospital in the United States, and we have a significant and growing presense in non-U.S. markets. Our mission is to create and deliver innovative healthcare solutions, developed in ethical collaboration with medical professionals, which enhance the quality of life for patients and improve the outcomes for our customers and shareholders.<\/p> <p><b>Dimension<\/b>: (Most Recent - Quarterly) - MRQ<\/p> <p><b>Statement<\/b>: Metrics<\/p> <p><b>Units<\/b>: currency/share<\/p> <p><b>Sector<\/b>: Healthcare<\/p> <p><b>Ticker<\/b>: COV<\/p> <p><b>Exchange<\/b>: NYSE<\/p> <p><b>Index Membership<\/b>: S&P500<\/p> ",
      "display_url": "http://www.sharadar.com/s/GrxxDFofSlKAGpNag",
      "frequency": "quarterly",
      "from_date": "2006-09-29",
      "id": 14041326,
      "name": "Covidien plc (NYSE:COV) - Free Cash Flow per Share (Most Recent - Quarterly)",
      "premium": true,
      "private": false,
      "source_code": "SF1",
      "source_name": "Core US Fundamentals Data",
      "to_date": "2014-09-26",
      "type": null,
      "updated_at": "2014-11-25T05:27:33.826Z",
      "urlize_name": "Covidien-plc-NYSE-COV-Free-Cash-Flow-per-Share-Most-Recent-Quarterly"
    },
    {
      "code": "COV_FCFPS_MRT",
      "column_names": [
        "Date",
        "Value"
      ],
      "description": "<p><b>Indicator Description<\/b> [Free Cash Flow per Share]: Free Cash Flow per Share is a valuation metric calculated by dividing <a href='COV_FCF_MRT'>[FCF]<\/a> by <a href='COV_SHARESWA_MRT'>[SHARESWA]<\/a>.<\/p> <p><b>Company Self Description<\/b> [Covidien plc]: We are a global leader in the development, manufacture and sale of healthcare products for use in clinical and home settings. Our products are found in almost every hospital in the United States, and we have a significant and growing presense in non-U.S. markets. Our mission is to create and deliver innovative healthcare solutions, developed in ethical collaboration with medical professionals, which enhance the quality of life for patients and improve the outcomes for our customers and shareholders.<\/p> <p><b>Dimension<\/b>: (Most Recent - Trailing Twelve Months) - MRT<\/p> <p><b>Statement<\/b>: Metrics<\/p> <p><b>Units<\/b>: currency/share<\/p> <p><b>Sector<\/b>: Healthcare<\/p> <p><b>Ticker<\/b>: COV<\/p> <p><b>Exchange<\/b>: NYSE<\/p> <p><b>Index Membership<\/b>: S&P500<\/p> ",
      "display_url": "http://www.sharadar.com/s/GrxxDFofSlKAGpNag",
      "frequency": "quarterly",
      "from_date": "2005-09-30",
      "id": 14041324,
      "name": "Covidien plc (NYSE:COV) - Free Cash Flow per Share (Most Recent - Trailing Twelve Months)",
      "premium": true,
      "private": false,
      "source_code": "SF1",
      "source_name": "Core US Fundamentals Data",
      "to_date": "2014-09-26",
      "type": null,
      "updated_at": "2014-11-25T05:27:35.118Z",
      "urlize_name": "Covidien-plc-NYSE-COV-Free-Cash-Flow-per-Share-Most-Recent-Trailing-Twelve-Months"
    },
    {
      "code": "COV_BVPS_ARQ",
      "column_names": [
        "Date",
        "Value"
      ],
      "description": "<p><b>Indicator Description<\/b> [Book Value per Share]: Measures the ratio between <a href='COV_EQUITY_ARQ'>[EQUITY]<\/a> and <a href='COV_SHARESWA_ARQ'>[SHARESWA]<\/a>.<\/p> <p><b>Company Self Description<\/b> [Covidien plc]: We are a global leader in the development, manufacture and sale of healthcare products for use in clinical and home settings. Our products are found in almost every hospital in the United States, and we have a significant and growing presense in non-U.S. markets. Our mission is to create and deliver innovative healthcare solutions, developed in ethical collaboration with medical professionals, which enhance the quality of life for patients and improve the outcomes for our customers and shareholders.<\/p> <p><b>Dimension<\/b>: (As Reported - Quarterly) - ARQ<\/p> <p><b>Statement<\/b>: Metrics<\/p> <p><b>Units<\/b>: currency/share<\/p> <p><b>Sector<\/b>: Healthcare<\/p> <p><b>Ticker<\/b>: COV<\/p> <p><b>Exchange<\/b>: NYSE<\/p> <p><b>Index Membership<\/b>: S&P500<\/p> ",
      "display_url": "http://www.sharadar.com/s/GrxxDFofSlKAGpNag",
      "frequency": "quarterly",
      "from_date": "2007-08-10",
      "id": 14041325,
      "name": "Covidien plc (NYSE:COV) - Book Value per Share (As Reported - Quarterly)",
      "premium": true,
      "private": false,
      "source_code": "SF1",
      "source_name": "Core US Fundamentals Data",
      "to_date": "2014-11-24",
      "type": null,
      "updated_at": "2014-11-25T05:27:34.729Z",
      "urlize_name": "Covidien-plc-NYSE-COV-Book-Value-per-Share-As-Reported-Quarterly"
    },
    {
      "code": "COV_BVPS_MRQ",
      "column_names": [
        "Date",
        "Value"
      ],
      "description": "<p><b>Indicator Description<\/b> [Book Value per Share]: Measures the ratio between <a href='COV_EQUITY_MRQ'>[EQUITY]<\/a> and <a href='COV_SHARESWA_MRQ'>[SHARESWA]<\/a>.<\/p> <p><b>Company Self Description<\/b> [Covidien plc]: We are a global leader in the development, manufacture and sale of healthcare products for use in clinical and home settings. Our products are found in almost every hospital in the United States, and we have a significant and growing presense in non-U.S. markets. Our mission is to create and deliver innovative healthcare solutions, developed in ethical collaboration with medical professionals, which enhance the quality of life for patients and improve the outcomes for our customers and shareholders.<\/p> <p><b>Dimension<\/b>: (Most Recent - Quarterly) - MRQ<\/p> <p><b>Statement<\/b>: Metrics<\/p> <p><b>Units<\/b>: currency/share<\/p> <p><b>Sector<\/b>: Healthcare<\/p> <p><b>Ticker<\/b>: COV<\/p> <p><b>Exchange<\/b>: NYSE<\/p> <p><b>Index Membership<\/b>: S&P500<\/p> ",
      "display_url": "http://www.sharadar.com/s/GrxxDFofSlKAGpNag",
      "frequency": "quarterly",
      "from_date": "2005-09-30",
      "id": 14041323,
      "name": "Covidien plc (NYSE:COV) - Book Value per Share (Most Recent - Quarterly)",
      "premium": true,
      "private": false,
      "source_code": "SF1",
      "source_name": "Core US Fundamentals Data",
      "to_date": "2014-09-26",
      "type": null,
      "updated_at": "2014-11-25T05:27:33.969Z",
      "urlize_name": "Covidien-plc-NYSE-COV-Book-Value-per-Share-Most-Recent-Quarterly"
    },
    {
      "code": "COV_DILUTIONRATIO_ARY",
      "column_names": [
        "Date",
        "Value"
      ],
      "description": "<p><b>Indicator Description<\/b> [Share Dilution Ratio]: Measures the ratio between <a href='COV_SHARESWADIL_ARY'>[SHARESWADIL]<\/a> and <a href='COV_SHARESWA_ARY'>[SHARESWA]<\/a>.<\/p> <p><b>Company Self Description<\/b> [Covidien plc]: We are a global leader in the development, manufacture and sale of healthcare products for use in clinical and home settings. Our products are found in almost every hospital in the United States, and we have a significant and growing presense in non-U.S. markets. Our mission is to create and deliver innovative healthcare solutions, developed in ethical collaboration with medical professionals, which enhance the quality of life for patients and improve the outcomes for our customers and shareholders.<\/p> <p><b>Dimension<\/b>: (As Reported - Annual) - ARY<\/p> <p><b>Statement<\/b>: Metrics<\/p> <p><b>Units<\/b>: %<\/p> <p><b>Sector<\/b>: Healthcare<\/p> <p><b>Ticker<\/b>: COV<\/p> <p><b>Exchange<\/b>: NYSE<\/p> <p><b>Index Membership<\/b>: S&P500<\/p> ",
      "display_url": "http://www.sharadar.com/s/GrxxDFofSlKAGpNag",
      "frequency": "annual",
      "from_date": "2007-12-13",
      "id": 14041277,
      "name": "Covidien plc (NYSE:COV) - Share Dilution Ratio (As Reported - Annual)",
      "premium": true,
      "private": false,
      "source_code": "SF1",
      "source_name": "Core US Fundamentals Data",
      "to_date": "2013-11-21",
      "type": null,
      "updated_at": "2014-11-25T05:27:34.201Z",
      "urlize_name": "Covidien-plc-NYSE-COV-Share-Dilution-Ratio-As-Reported-Annual"
    },
    {
      "code": "COV_WORKINGCAPITAL_MRQ",
      "column_names": [
        "Date",
        "Value"
      ],
      "description": "<p><b>Indicator Description<\/b> [Working Capital]: Working capital measures the difference between <a href='COV_ASSETSC_MRQ'>[ASSETSC]<\/a> and <a href='COV_LIABILITIESC_MRQ'>[LIABILITIESC]<\/a>.<\/p> <p><b>Company Self Description<\/b> [Covidien plc]: We are a global leader in the development, manufacture and sale of healthcare products for use in clinical and home settings. Our products are found in almost every hospital in the United States, and we have a significant and growing presense in non-U.S. markets. Our mission is to create and deliver innovative healthcare solutions, developed in ethical collaboration with medical professionals, which enhance the quality of life for patients and improve the outcomes for our customers and shareholders.<\/p> <p><b>Dimension<\/b>: (Most Recent - Quarterly) - MRQ<\/p> <p><b>Statement<\/b>: Metrics<\/p> <p><b>Units<\/b>: currency<\/p> <p><b>Sector<\/b>: Healthcare<\/p> <p><b>Ticker<\/b>: COV<\/p> <p><b>Exchange<\/b>: NYSE<\/p> <p><b>Index Membership<\/b>: S&P500<\/p> ",
      "display_url": "http://www.sharadar.com/s/GrxxDFofSlKAGpNag",
      "frequency": "quarterly",
      "from_date": "2005-09-30",
      "id": 14041320,
      "name": "Covidien plc (NYSE:COV) - Working Capital (Most Recent - Quarterly)",
      "premium": true,
      "private": false,
      "source_code": "SF1",
      "source_name": "Core US Fundamentals Data",
      "to_date": "2014-09-26",
      "type": null,
      "updated_at": "2014-11-25T05:27:34.809Z",
      "urlize_name": "Covidien-plc-NYSE-COV-Working-Capital-Most-Recent-Quarterly"
    },
    {
      "code": "COV_DILUTIONRATIO_ART",
      "column_names": [
        "Date",
        "Value"
      ],
      "description": "<p><b>Indicator Description<\/b> [Share Dilution Ratio]: Measures the ratio between <a href='COV_SHARESWADIL_ART'>[SHARESWADIL]<\/a> and <a href='COV_SHARESWA_ART'>[SHARESWA]<\/a>.<\/p> <p><b>Company Self Description<\/b> [Covidien plc]: We are a global leader in the development, manufacture and sale of healthcare products for use in clinical and home settings. Our products are found in almost every hospital in the United States, and we have a significant and growing presense in non-U.S. markets. Our mission is to create and deliver innovative healthcare solutions, developed in ethical collaboration with medical professionals, which enhance the quality of life for patients and improve the outcomes for our customers and shareholders.<\/p> <p><b>Dimension<\/b>: (As Reported - Trailing Twelve Months) - ART<\/p> <p><b>Statement<\/b>: Metrics<\/p> <p><b>Units<\/b>: %<\/p> <p><b>Sector<\/b>: Healthcare<\/p> <p><b>Ticker<\/b>: COV<\/p> <p><b>Exchange<\/b>: NYSE<\/p> <p><b>Index Membership<\/b>: S&P500<\/p> ",
      "display_url": "http://www.sharadar.com/s/GrxxDFofSlKAGpNag",
      "frequency": "quarterly",
      "from_date": "2007-12-13",
      "id": 14041282,
      "name": "Covidien plc (NYSE:COV) - Share Dilution Ratio (As Reported - Trailing Twelve Months)",
      "premium": true,
      "private": false,
      "source_code": "SF1",
      "source_name": "Core US Fundamentals Data",
      "to_date": "2014-07-30",
      "type": null,
      "updated_at": "2014-11-25T05:27:34.813Z",
      "urlize_name": "Covidien-plc-NYSE-COV-Share-Dilution-Ratio-As-Reported-Trailing-Twelve-Months"
    },
    {
      "code": "COV_DILUTIONRATIO_MRQ",
      "column_names": [
        "Date",
        "Value"
      ],
      "description": "<p><b>Indicator Description<\/b> [Share Dilution Ratio]: Measures the ratio between <a href='COV_SHARESWADIL_MRQ'>[SHARESWADIL]<\/a> and <a href='COV_SHARESWA_MRQ'>[SHARESWA]<\/a>.<\/p> <p><b>Company Self Description<\/b> [Covidien plc]: We are a global leader in the development, manufacture and sale of healthcare products for use in clinical and home settings. Our products are found in almost every hospital in the United States, and we have a significant and growing presense in non-U.S. markets. Our mission is to create and deliver innovative healthcare solutions, developed in ethical collaboration with medical professionals, which enhance the quality of life for patients and improve the outcomes for our customers and shareholders.<\/p> <p><b>Dimension<\/b>: (Most Recent - Quarterly) - MRQ<\/p> <p><b>Statement<\/b>: Metrics<\/p> <p><b>Units<\/b>: %<\/p> <p><b>Sector<\/b>: Healthcare<\/p> <p><b>Ticker<\/b>: COV<\/p> <p><b>Exchange<\/b>: NYSE<\/p> <p><b>Index Membership<\/b>: S&P500<\/p> ",
      "display_url": "http://www.sharadar.com/s/GrxxDFofSlKAGpNag",
      "frequency": "quarterly",
      "from_date": "2006-12-29",
      "id": 14041284,
      "name": "Covidien plc (NYSE:COV) - Share Dilution Ratio (Most Recent - Quarterly)",
      "premium": true,
      "private": false,
      "source_code": "SF1",
      "source_name": "Core US Fundamentals Data",
      "to_date": "2014-06-27",
      "type": null,
      "updated_at": "2014-11-25T05:27:34.905Z",
      "urlize_name": "Covidien-plc-NYSE-COV-Share-Dilution-Ratio-Most-Recent-Quarterly"
    },
    {
      "code": "COV_DILUTIONRATIO_MRT",
      "column_names": [
        "Date",
        "Value"
      ],
      "description": "<p><b>Indicator Description<\/b> [Share Dilution Ratio]: Measures the ratio between <a href='COV_SHARESWADIL_MRT'>[SHARESWADIL]<\/a> and <a href='COV_SHARESWA_MRT'>[SHARESWA]<\/a>.<\/p> <p><b>Company Self Description<\/b> [Covidien plc]: We are a global leader in the development, manufacture and sale of healthcare products for use in clinical and home settings. Our products are found in almost every hospital in the United States, and we have a significant and growing presense in non-U.S. markets. Our mission is to create and deliver innovative healthcare solutions, developed in ethical collaboration with medical professionals, which enhance the quality of life for patients and improve the outcomes for our customers and shareholders.<\/p> <p><b>Dimension<\/b>: (Most Recent - Trailing Twelve Months) - MRT<\/p> <p><b>Statement<\/b>: Metrics<\/p> <p><b>Units<\/b>: %<\/p> <p><b>Sector<\/b>: Healthcare<\/p> <p><b>Ticker<\/b>: COV<\/p> <p><b>Exchange<\/b>: NYSE<\/p> <p><b>Index Membership<\/b>: S&P500<\/p> ",
      "display_url": "http://www.sharadar.com/s/GrxxDFofSlKAGpNag",
      "frequency": "quarterly",
      "from_date": "2005-09-30",
      "id": 14041283,
      "name": "Covidien plc (NYSE:COV) - Share Dilution Ratio (Most Recent - Trailing Twelve Months)",
      "premium": true,
      "private": false,
      "source_code": "SF1",
      "source_name": "Core US Fundamentals Data",
      "to_date": "2014-06-27",
      "type": null,
      "updated_at": "2014-11-25T05:27:35.165Z",
      "urlize_name": "Covidien-plc-NYSE-COV-Share-Dilution-Ratio-Most-Recent-Trailing-Twelve-Months"
    },
    {
      "code": "COV_SHARESWADIL_ARQ",
      "column_names": [
        "Date",
        "Value"
      ],
      "description": "<p><b>Indicator Description<\/b> [Weighted Average Shares Diluted]: The average number of shares or units issued and outstanding that are used in calculating <a href='COV_EPSDIL_ARQ'>[EPSDIL]<\/a>, determined based on the timing of issuance of shares or units in the period.<\/p> <p><b>Company Self Description<\/b> [Covidien plc]: We are a global leader in the development, manufacture and sale of healthcare products for use in clinical and home settings. Our products are found in almost every hospital in the United States, and we have a significant and growing presense in non-U.S. markets. Our mission is to create and deliver innovative healthcare solutions, developed in ethical collaboration with medical professionals, which enhance the quality of life for patients and improve the outcomes for our customers and shareholders.<\/p> <p><b>Dimension<\/b>: (As Reported - Quarterly) - ARQ<\/p> <p><b>Statement<\/b>: Income Statement<\/p> <p><b>Units<\/b>: shares<\/p> <p><b>Sector<\/b>: Healthcare<\/p> <p><b>Ticker<\/b>: COV<\/p> <p><b>Exchange<\/b>: NYSE<\/p> <p><b>Index Membership<\/b>: S&P500<\/p> ",
      "display_url": "http://www.sharadar.com/s/GrxxDFofSlKAGpNag",
      "frequency": "quarterly",
      "from_date": "2008-02-11",
      "id": 14041154,
      "name": "Covidien plc (NYSE:COV) - Weighted Average Shares Diluted (As Reported - Quarterly)",
      "premium": true,
      "private": false,
      "source_code": "SF1",
      "source_name": "Core US Fundamentals Data",
      "to_date": "2014-07-30",
      "type": null,
      "updated_at": "2014-11-25T05:27:35.262Z",
      "urlize_name": "Covidien-plc-NYSE-COV-Weighted-Average-Shares-Diluted-As-Reported-Quarterly"
    },
    {
      "code": "COV_DILUTIONRATIO_ARQ",
      "column_names": [
        "Date",
        "Value"
      ],
      "description": "<p><b>Indicator Description<\/b> [Share Dilution Ratio]: Measures the ratio between <a href='COV_SHARESWADIL_ARQ'>[SHARESWADIL]<\/a> and <a href='COV_SHARESWA_ARQ'>[SHARESWA]<\/a>.<\/p> <p><b>Company Self Description<\/b> [Covidien plc]: We are a global leader in the development, manufacture and sale of healthcare products for use in clinical and home settings. Our products are found in almost every hospital in the United States, and we have a significant and growing presense in non-U.S. markets. Our mission is to create and deliver innovative healthcare solutions, developed in ethical collaboration with medical professionals, which enhance the quality of life for patients and improve the outcomes for our customers and shareholders.<\/p> <p><b>Dimension<\/b>: (As Reported - Quarterly) - ARQ<\/p> <p><b>Statement<\/b>: Metrics<\/p> <p><b>Units<\/b>: %<\/p> <p><b>Sector<\/b>: Healthcare<\/p> <p><b>Ticker<\/b>: COV<\/p> <p><b>Exchange<\/b>: NYSE<\/p> <p><b>Index Membership<\/b>: S&P500<\/p> ",
      "display_url": "http://www.sharadar.com/s/GrxxDFofSlKAGpNag",
      "frequency": "quarterly",
      "from_date": "2008-02-11",
      "id": 14041279,
      "name": "Covidien plc (NYSE:COV) - Share Dilution Ratio (As Reported - Quarterly)",
      "premium": true,
      "private": false,
      "source_code": "SF1",
      "source_name": "Core US Fundamentals Data",
      "to_date": "2014-07-30",
      "type": null,
      "updated_at": "2014-11-25T05:27:35.072Z",
      "urlize_name": "Covidien-plc-NYSE-COV-Share-Dilution-Ratio-As-Reported-Quarterly"
    },
    {
      "code": "COV_DILUTIONRATIO_MRY",
      "column_names": [
        "Date",
        "Value"
      ],
      "description": "<p><b>Indicator Description<\/b> [Share Dilution Ratio]: Measures the ratio between <a href='COV_SHARESWADIL_MRY'>[SHARESWADIL]<\/a> and <a href='COV_SHARESWA_MRY'>[SHARESWA]<\/a>.<\/p> <p><b>Company Self Description<\/b> [Covidien plc]: We are a global leader in the development, manufacture and sale of healthcare products for use in clinical and home settings. Our products are found in almost every hospital in the United States, and we have a significant and growing presense in non-U.S. markets. Our mission is to create and deliver innovative healthcare solutions, developed in ethical collaboration with medical professionals, which enhance the quality of life for patients and improve the outcomes for our customers and shareholders.<\/p> <p><b>Dimension<\/b>: (Most Recent - Annual) - MRY<\/p> <p><b>Statement<\/b>: Metrics<\/p> <p><b>Units<\/b>: %<\/p> <p><b>Sector<\/b>: Healthcare<\/p> <p><b>Ticker<\/b>: COV<\/p> <p><b>Exchange<\/b>: NYSE<\/p> <p><b>Index Membership<\/b>: S&P500<\/p> ",
      "display_url": "http://www.sharadar.com/s/GrxxDFofSlKAGpNag",
      "frequency": "annual",
      "from_date": "2005-09-30",
      "id": 14041278,
      "name": "Covidien plc (NYSE:COV) - Share Dilution Ratio (Most Recent - Annual)",
      "premium": true,
      "private": false,
      "source_code": "SF1",
      "source_name": "Core US Fundamentals Data",
      "to_date": "2013-09-27",
      "type": null,
      "updated_at": "2014-11-25T05:27:35.301Z",
      "urlize_name": "Covidien-plc-NYSE-COV-Share-Dilution-Ratio-Most-Recent-Annual"
    },
    {
      "code": "COV_SHARESWADIL_MRQ",
      "column_names": [
        "Date",
        "Value"
      ],
      "description": "<p><b>Indicator Description<\/b> [Weighted Average Shares Diluted]: The average number of shares or units issued and outstanding that are used in calculating <a href='COV_EPSDIL_MRQ'>[EPSDIL]<\/a>, determined based on the timing of issuance of shares or units in the period.<\/p> <p><b>Company Self Description<\/b> [Covidien plc]: We are a global leader in the development, manufacture and sale of healthcare products for use in clinical and home settings. Our products are found in almost every hospital in the United States, and we have a significant and growing presense in non-U.S. markets. Our mission is to create and deliver innovative healthcare solutions, developed in ethical collaboration with medical professionals, which enhance the quality of life for patients and improve the outcomes for our customers and shareholders.<\/p> <p><b>Dimension<\/b>: (Most Recent - Quarterly) - MRQ<\/p> <p><b>Statement<\/b>: Income Statement<\/p> <p><b>Units<\/b>: shares<\/p> <p><b>Sector<\/b>: Healthcare<\/p> <p><b>Ticker<\/b>: COV<\/p> <p><b>Exchange<\/b>: NYSE<\/p> <p><b>Index Membership<\/b>: S&P500<\/p> ",
      "display_url": "http://www.sharadar.com/s/GrxxDFofSlKAGpNag",
      "frequency": "quarterly",
      "from_date": "2006-12-29",
      "id": 14041215,
      "name": "Covidien plc (NYSE:COV) - Weighted Average Shares Diluted (Most Recent - Quarterly)",
      "premium": true,
      "private": false,
      "source_code": "SF1",
      "source_name": "Core US Fundamentals Data",
      "to_date": "2014-06-27",
      "type": null,
      "updated_at": "2014-11-25T05:27:35.316Z",
      "urlize_name": "Covidien-plc-NYSE-COV-Weighted-Average-Shares-Diluted-Most-Recent-Quarterly"
    },
    {
      "code": "COV_SHARESWADIL_ARY",
      "column_names": [
        "Date",
        "Value"
      ],
      "description": "<p><b>Indicator Description<\/b> [Weighted Average Shares Diluted]: The average number of shares or units issued and outstanding that are used in calculating <a href='COV_EPSDIL_ARY'>[EPSDIL]<\/a>, determined based on the timing of issuance of shares or units in the period.<\/p> <p><b>Company Self Description<\/b> [Covidien plc]: We are a global leader in the development, manufacture and sale of healthcare products for use in clinical and home settings. Our products are found in almost every hospital in the United States, and we have a significant and growing presense in non-U.S. markets. Our mission is to create and deliver innovative healthcare solutions, developed in ethical collaboration with medical professionals, which enhance the quality of life for patients and improve the outcomes for our customers and shareholders.<\/p> <p><b>Dimension<\/b>: (As Reported - Annual) - ARY<\/p> <p><b>Statement<\/b>: Income Statement<\/p> <p><b>Units<\/b>: shares<\/p> <p><b>Sector<\/b>: Healthcare<\/p> <p><b>Ticker<\/b>: COV<\/p> <p><b>Exchange<\/b>: NYSE<\/p> <p><b>Index Membership<\/b>: S&P500<\/p> ",
      "display_url": "http://www.sharadar.com/s/GrxxDFofSlKAGpNag",
      "frequency": "annual",
      "from_date": "2007-12-13",
      "id": 14041157,
      "name": "Covidien plc (NYSE:COV) - Weighted Average Shares Diluted (As Reported - Annual)",
      "premium": true,
      "private": false,
      "source_code": "SF1",
      "source_name": "Core US Fundamentals Data",
      "to_date": "2013-11-21",
      "type": null,
      "updated_at": "2014-11-25T05:27:35.741Z",
      "urlize_name": "Covidien-plc-NYSE-COV-Weighted-Average-Shares-Diluted-As-Reported-Annual"
    },
    {
      "code": "COV_SHARESWADIL_ART",
      "column_names": [
        "Date",
        "Value"
      ],
      "description": "<p><b>Indicator Description<\/b> [Weighted Average Shares Diluted]: The average number of shares or units issued and outstanding that are used in calculating <a href='COV_EPSDIL_ART'>[EPSDIL]<\/a>, determined based on the timing of issuance of shares or units in the period.<\/p> <p><b>Company Self Description<\/b> [Covidien plc]: We are a global leader in the development, manufacture and sale of healthcare products for use in clinical and home settings. Our products are found in almost every hospital in the United States, and we have a significant and growing presense in non-U.S. markets. Our mission is to create and deliver innovative healthcare solutions, developed in ethical collaboration with medical professionals, which enhance the quality of life for patients and improve the outcomes for our customers and shareholders.<\/p> <p><b>Dimension<\/b>: (As Reported - Trailing Twelve Months) - ART<\/p> <p><b>Statement<\/b>: Income Statement<\/p> <p><b>Units<\/b>: shares<\/p> <p><b>Sector<\/b>: Healthcare<\/p> <p><b>Ticker<\/b>: COV<\/p> <p><b>Exchange<\/b>: NYSE<\/p> <p><b>Index Membership<\/b>: S&P500<\/p> ",
      "display_url": "http://www.sharadar.com/s/GrxxDFofSlKAGpNag",
      "frequency": "quarterly",
      "from_date": "2007-12-13",
      "id": 14041155,
      "name": "Covidien plc (NYSE:COV) - Weighted Average Shares Diluted (As Reported - Trailing Twelve Months)",
      "premium": true,
      "private": false,
      "source_code": "SF1",
      "source_name": "Core US Fundamentals Data",
      "to_date": "2014-07-30",
      "type": null,
      "updated_at": "2014-11-25T05:27:35.409Z",
      "urlize_name": "Covidien-plc-NYSE-COV-Weighted-Average-Shares-Diluted-As-Reported-Trailing-Twelve-Months"
    },
    {
      "code": "COV_SHARESWADIL_MRT",
      "column_names": [
        "Date",
        "Value"
      ],
      "description": "<p><b>Indicator Description<\/b> [Weighted Average Shares Diluted]: The average number of shares or units issued and outstanding that are used in calculating <a href='COV_EPSDIL_MRT'>[EPSDIL]<\/a>, determined based on the timing of issuance of shares or units in the period.<\/p> <p><b>Company Self Description<\/b> [Covidien plc]: We are a global leader in the development, manufacture and sale of healthcare products for use in clinical and home settings. Our products are found in almost every hospital in the United States, and we have a significant and growing presense in non-U.S. markets. Our mission is to create and deliver innovative healthcare solutions, developed in ethical collaboration with medical professionals, which enhance the quality of life for patients and improve the outcomes for our customers and shareholders.<\/p> <p><b>Dimension<\/b>: (Most Recent - Trailing Twelve Months) - MRT<\/p> <p><b>Statement<\/b>: Income Statement<\/p> <p><b>Units<\/b>: shares<\/p> <p><b>Sector<\/b>: Healthcare<\/p> <p><b>Ticker<\/b>: COV<\/p> <p><b>Exchange<\/b>: NYSE<\/p> <p><b>Index Membership<\/b>: S&P500<\/p> ",
      "display_url": "http://www.sharadar.com/s/GrxxDFofSlKAGpNag",
      "frequency": "quarterly",
      "from_date": "2005-09-30",
      "id": 14041216,
      "name": "Covidien plc (NYSE:COV) - Weighted Average Shares Diluted (Most Recent - Trailing Twelve Months)",
      "premium": true,
      "private": false,
      "source_code": "SF1",
      "source_name": "Core US Fundamentals Data",
      "to_date": "2014-06-27",
      "type": null,
      "updated_at": "2014-11-25T05:27:35.419Z",
      "urlize_name": "Covidien-plc-NYSE-COV-Weighted-Average-Shares-Diluted-Most-Recent-Trailing-Twelve-Months"
    },
    {
      "code": "COV_SHARESWADIL_MRY",
      "column_names": [
        "Date",
        "Value"
      ],
      "description": "<p><b>Indicator Description<\/b> [Weighted Average Shares Diluted]: The average number of shares or units issued and outstanding that are used in calculating <a href='COV_EPSDIL_MRY'>[EPSDIL]<\/a>, determined based on the timing of issuance of shares or units in the period.<\/p> <p><b>Company Self Description<\/b> [Covidien plc]: We are a global leader in the development, manufacture and sale of healthcare products for use in clinical and home settings. Our products are found in almost every hospital in the United States, and we have a significant and growing presense in non-U.S. markets. Our mission is to create and deliver innovative healthcare solutions, developed in ethical collaboration with medical professionals, which enhance the quality of life for patients and improve the outcomes for our customers and shareholders.<\/p> <p><b>Dimension<\/b>: (Most Recent - Annual) - MRY<\/p> <p><b>Statement<\/b>: Income Statement<\/p> <p><b>Units<\/b>: shares<\/p> <p><b>Sector<\/b>: Healthcare<\/p> <p><b>Ticker<\/b>: COV<\/p> <p><b>Exchange<\/b>: NYSE<\/p> <p><b>Index Membership<\/b>: S&P500<\/p> ",
      "display_url": "http://www.sharadar.com/s/GrxxDFofSlKAGpNag",
      "frequency": "annual",
      "from_date": "2005-09-30",
      "id": 14041226,
      "name": "Covidien plc (NYSE:COV) - Weighted Average Shares Diluted (Most Recent - Annual)",
      "premium": true,
      "private": false,
      "source_code": "SF1",
      "source_name": "Core US Fundamentals Data",
      "to_date": "2013-09-27",
      "type": null,
      "updated_at": "2014-11-25T05:27:35.478Z",
      "urlize_name": "Covidien-plc-NYSE-COV-Weighted-Average-Shares-Diluted-Most-Recent-Annual"
    },
    {
      "code": "RKT_NETMARGIN_MRT",
      "column_names": [
        "Date",
        "Value"
      ],
      "description": "<p><b>Indicator Description<\/b> [Profit Margin]: Measures the ratio between a companies <a href='RKT_NETINCCMN_MRT'>[NETINCCMN]<\/a> and <a href='RKT_REVENUE_MRT'>[REVENUE]<\/a>.<\/p> <p><b>Company Self Description<\/b> [Rock-Tenn CO]: We are one of North America's leading integrated manufacturers of corrugated and consumer packaging. We report our results of operations in three segments: Corrugated Packaging; Consumer Packaging; and, Recycling.<\/p> <p><b>Dimension<\/b>: (Most Recent - Trailing Twelve Months) - MRT<\/p> <p><b>Statement<\/b>: Metrics<\/p> <p><b>Units<\/b>: %<\/p> <p><b>Sector<\/b>: Consumer Goods<\/p> <p><b>Ticker<\/b>: RKT<\/p> <p><b>Exchange<\/b>: NYSE<\/p> <p><b>Index Membership<\/b>: S&P400, RUSSELL1000<\/p> ",
      "display_url": "http://www.sharadar.com/s/oqdxtxxXpgNZTxcXt",
      "frequency": "quarterly",
      "from_date": "2004-03-31",
      "id": 14062831,
      "name": "Rock-Tenn CO (NYSE:RKT) - Profit Margin (Most Recent - Trailing Twelve Months)",
      "premium": true,
      "private": false,
      "source_code": "SF1",
      "source_name": "Core US Fundamentals Data",
      "to_date": "2014-09-30",
      "type": null,
      "updated_at": "2014-11-25T05:26:37.149Z",
      "urlize_name": "Rock-Tenn-CO-NYSE-RKT-Profit-Margin-Most-Recent-Trailing-Twelve-Months"
    }
  ],
  "per_page": 20,
  "sources": [{
    "code": "SF1",
    "datasets_count": 625509,
    "description": "Updated daily, 69 indicators, more than 2,500 companies, up to 10 years history, incl/excl restatements, continuously expanding coverage.",
    "host": "www.sharadar.com",
    "id": 12908,
    "name": "Core US Fundamentals Data",
    "premium": true,
    "subscribed": false
  }],
  "total_count": 12140935
}
